Curis
CRIS
#11008
Rank
ยฃ3.04 M
Marketcap
ยฃ1.26
Share price
-5.56%
Change (1 day)
-2.16%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -ยฃ5.06 Million

According to Curis's latest financial reports the company's current earnings are ยฃ7.06 Million. In 2025 the company made an earning of -ยฃ3.99 Million, an increase over its 2024 earnings that were of -ยฃ31.58 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ5.06 Million26.87%
2025 -ยฃ3.99 Million-87.38%
2024 -ยฃ31.58 Million-5.77%
2023 -ยฃ33.52 Million-13.1%
2022 -ยฃ38.57 Million27.52%
2021 -ยฃ30.25 Million65.09%
2020 -ยฃ18.32 Million-9.1%
2019 -ยฃ20.16 Million-4.73%
2018 -ยฃ21.16 Million-41.95%
2017 -ยฃ36.44 Million-14.37%
2016 -ยฃ42.55 Million3.55%
2015 -ยฃ41.09 Million271.52%
2014 -ยฃ11.06 Million76.64%
2013 -ยฃ6.27 Million
2011 -ยฃ5.32 Million27.76%
2010 -ยฃ4.17 Million-43.87%
2009 -ยฃ7.42 Million-23.44%
2008 -ยฃ9.69 Million56.66%
2007 -ยฃ6.19 Million-16.71%
2006 -ยฃ7.43 Million-36.92%
2005 -ยฃ11.77 Million156.25%
2004 -ยฃ4.6 Million-37.24%
2003 -ยฃ7.32 Million-93.34%
2002 -ยฃ0.11 Billion86.79%
2001 -ยฃ58.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ7.81 B-156,794.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ7.08 B-142,088.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-ยฃ45.69 Million 815.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
ยฃ0.74 B-14,942.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.23 Billion 4,472.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-ยฃ16.39 Million 228.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ43.63 M-974.39%๐Ÿ‡บ๐Ÿ‡ธ USA